WO2013121279A3 - Process to prepare ertapenem - Google Patents
Process to prepare ertapenem Download PDFInfo
- Publication number
- WO2013121279A3 WO2013121279A3 PCT/IB2013/000211 IB2013000211W WO2013121279A3 WO 2013121279 A3 WO2013121279 A3 WO 2013121279A3 IB 2013000211 W IB2013000211 W IB 2013000211W WO 2013121279 A3 WO2013121279 A3 WO 2013121279A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ertapenem
- prepare
- prepare ertapenem
- lutidine
- methylmorpholine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
The present invention relates to a novel process for the preparation of Ertapenem of formula (I) or salt thereof, using hydrogenation catalyst in presence of N-methylmorpholine, 2,6-Lutidine or mixture thereof.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN547CH2012 | 2012-02-14 | ||
IN547/CHE/2012 | 2012-02-14 | ||
IN3084/CHE/2012 | 2012-07-27 | ||
IN3084CH2012 | 2012-07-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013121279A2 WO2013121279A2 (en) | 2013-08-22 |
WO2013121279A3 true WO2013121279A3 (en) | 2014-09-12 |
Family
ID=47997590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2013/000211 WO2013121279A2 (en) | 2012-02-14 | 2013-02-11 | Process to prepare ertapenem |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013121279A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104788453B (en) * | 2014-01-16 | 2017-02-15 | 浙江九洲药业股份有限公司 | One-pot preparation process of monosodium ertapenem |
US10434089B2 (en) | 2017-01-25 | 2019-10-08 | The Johns Hopkins University | Avibactam and carbapenems antibacterial agents |
CN110698479A (en) * | 2018-07-09 | 2020-01-17 | 武汉启瑞药业有限公司 | Synthetic method of ertapenem monosodium salt |
CN113880839A (en) * | 2021-11-01 | 2022-01-04 | 石药集团中诺药业(石家庄)有限公司 | Novel synthesis method of ertapenem sodium crude product |
CN114105988B (en) * | 2022-01-24 | 2022-04-29 | 深圳市海滨制药有限公司 | Synthetic method of ertapenem sodium |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5478820A (en) * | 1992-02-04 | 1995-12-26 | Zeneca Ltd. | Antibiotic compounds |
US7071330B2 (en) * | 2001-01-16 | 2006-07-04 | Williams John M | Process for carbapenem synthesis |
US20090312539A1 (en) * | 2006-11-20 | 2009-12-17 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of carbapenem antibiotic |
EP2141167A1 (en) * | 2008-07-04 | 2010-01-06 | ACS DOBFAR S.p.A. | Process for synthesizing carbapenem using raney nickel |
EP2388261A2 (en) * | 2010-05-19 | 2011-11-23 | Savior Lifetec Corporation | Improved process for the preparation of carbapenem using carbapenem intermediates and recovery of carbapenem |
-
2013
- 2013-02-11 WO PCT/IB2013/000211 patent/WO2013121279A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5478820A (en) * | 1992-02-04 | 1995-12-26 | Zeneca Ltd. | Antibiotic compounds |
US7071330B2 (en) * | 2001-01-16 | 2006-07-04 | Williams John M | Process for carbapenem synthesis |
US20090312539A1 (en) * | 2006-11-20 | 2009-12-17 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of carbapenem antibiotic |
EP2141167A1 (en) * | 2008-07-04 | 2010-01-06 | ACS DOBFAR S.p.A. | Process for synthesizing carbapenem using raney nickel |
EP2388261A2 (en) * | 2010-05-19 | 2011-11-23 | Savior Lifetec Corporation | Improved process for the preparation of carbapenem using carbapenem intermediates and recovery of carbapenem |
Also Published As
Publication number | Publication date |
---|---|
WO2013121279A2 (en) | 2013-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010007587A (en) | Compounds comprising a cyclobutoxy group. | |
IN2015KN00262A (en) | ||
PH12015500211A1 (en) | 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes | |
MX2011008864A (en) | Sulfonylated tetrahydroazolopyrazines and their use as medicinal products. | |
TN2014000138A1 (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. | |
WO2011138281A3 (en) | Process for the preparation of dithiine tetracarboxydiimides | |
PL2791093T3 (en) | Process for the preparation of 2, 3, 3, 3 tetrafluoropropene | |
CA2830549C (en) | Methods and compositions for preparing noribogaine from voacangine | |
WO2010102778A3 (en) | Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators | |
WO2011132051A3 (en) | Tricycle compounds as phosphodiesterase-10 inhibitors | |
PH12014501195A1 (en) | Novel 2h-indazoles as ep2, receptor antagonists | |
WO2013068850A8 (en) | PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES | |
MX2014014138A (en) | New process for the preparation of 2-cyclopentyl-6-methoxy-isonic otinic acid. | |
GB201100531D0 (en) | Functionalised materials, processes for the production and uses thereof | |
WO2013121279A3 (en) | Process to prepare ertapenem | |
PH12014501712A1 (en) | Novel morpholinyl derivatives useful as mogat-2-inhibitors | |
WO2010079045A3 (en) | Crystalline salt forms of flibanserine | |
WO2012140490A3 (en) | Processes for preparing pitavastatin calcium | |
MX350430B (en) | Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-m ethyl-pentanoic acid compounds. | |
WO2014087208A3 (en) | A process of preparing alcaftadine | |
WO2014068333A3 (en) | New process | |
MX2014004210A (en) | 2-oxo-piperidinyl derivatives. | |
IN2015DN00950A (en) | ||
HK1215244A1 (en) | Process for the preparation of (1s,4s,5s)-4-bromo-6- oxabicyclo[3.2.1]octan-7-one (1s4s5s)-4--6-[321]-7- | |
WO2012063115A3 (en) | Process for the preparation of rosuvastatin calcium via novel amine intermediate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13711946 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13711946 Country of ref document: EP Kind code of ref document: A2 |